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Background: Intracoronary administration of bone-marrow derived stem cells improves myocardial blood flow and function in patients with acute 
myocardial infarction.1 However, the efficacy has been limited by low cell retention and possible distal embolisation of atherothrombotic debris. The 
objective of this study was to evaluate the potential of a novel less invasive intrapericardial route for xenogenic microencapsulated stem cell delivery 
using x-ray fused with magnetic resonance imaging (XFM) guidance.
Methods: XCaps containing human mesenchymal stem cell (hMSC) were prepared using a modified alginate microencapsulation method. Female 
Yorkshire pigs (~25 kg, n=10) were randomized to receive empty XCaps, naked hMSCs, saline, or XCap-encapsulated hMSCs via a percutaneous 
subxiphoid approach. Prior to delivery, ECG-gated cine breath-held short-axis images were acquired on a 1.5 T scanner to determine ventricular 
function. A navigator-gated 3D whole heart MRI was then obtained to contour ventricular borders for intrapericardial injection. A cardiac-gated c-arm 
CT (dynaCT) was then fused with the whole heart MRI and overlaid on live fluoroscopy to guide percutaneous access to the pericardial sac. Animals 
were sacrificed immediately or 1 week post-delivery for histological analysis.
Results: In vitro viability of hMSCs remained high (>95%) after encapsulation. Under XFM guidance, successful intrapericardial access and delivery 
of XCaps was achieved in all animals without conduction abnormalities. XCaps were visiable on c-arm CT images immediately and 1 week after 
delivery. Pericardial adhesions and effusion were absent and cardiac function was preserved 1week post-delivery. XCap-encapsulated hMSCs within 
XCaps in the pericardial space were easily detected postmortem using human nucleic antigen staining while naked hMSCs were seldom retained.
Conclusion: XFM guided intrapericardial delivery approach provides a safe and minimally invasive means to reliably deliver cellular therapeutics, 
improve cell retention and enable x-ray tracking of stem cells in the heart.
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